SAN DIEGO, April 08, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a study published in The Journal of Molecular Diagnostics
Bionano is a California-based health-tech company that develops software products offering solutions such as genome mapping and analysis for the healthcare sector.